论文部分内容阅读
目的对盐酸利托君在未足月胎膜早破中的应用效果进行探讨。方法取我院2015年1月-2016年10月收治的100例未足月胎膜早破患者为研究对象。分成两组,50例患者实施常规治疗,设为对照组;50例患者同时取盐酸利托君进行治疗,设为实验组。观察患者的治疗情况,并进行比较。结果实验组的总有效率高于对照组,数据比较显示差异性明显,有统计学意义,P<0.05;实验组的治疗时间、宫缩抑制时间比对照组短,实验组妊娠延长时间比对照组长,数据比较显示差异性明显,有统计学意义,P<0.05;实验组的妊娠孕周>35周分娩率、胎儿出生后存活率高于对照组,数据比较显示差异性明显,有统计学意义,P<0.05。结论未足月胎膜早破患者应用盐酸利托君进行治疗,可改善产妇的妊娠结局,提高胎儿存活率,安全性高。
Objective To investigate the effect of Rituxuron Hydrochloride in preterm premature rupture of membranes. Methods From January 2015 to October 2016 in our hospital, 100 cases of premature rupture of membranes were enrolled in this study. Divided into two groups, 50 patients underwent routine treatment, as the control group; 50 patients were treated with ritodrine hydrochloride at the same time, as the experimental group. Observe the patient’s treatment and compare. Results The total effective rate of the experimental group was higher than that of the control group, the data showed significant difference, P <0.05; the treatment time of the experimental group, contractions time shorter than the control group, The data showed that the difference was statistically significant, P <0.05; experimental group of gestational weeks> 35 weeks delivery rate, fetal survival after birth was higher than the control group, the data showed significant differences, there are statistics Significance, P <0.05. Conclusion The treatment of premature rupture of membranes in patients with premature rupture of membranes using ritodrine hydrochloride can improve maternal pregnancy outcomes, improve fetal survival rate, and high safety.